한빛사논문
- 조회1,362
Eui-Jun Kim1,5, Peng Liu4,5, Shengjie Zhang1, Kristine Donahue1,5, Yidan Wang1,5, Jennifer L. Schehr3,5, Serena K. Wolfe3,5, Amber Dickerson6, Li Lu7,8, Lixin Rui2,5, Xuehua Zhong7,8, Kari B. Wisinski3,5, Min Yu6, Aussie Suzuki1,5, Joshua M. Lang3,5, Irene M. Ong2,4,5 and Wei Xu1,5,*
1McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA, 2Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706, USA, 3Department of Medicine, University of Wisconsin, Madison, WI 53706, USA, 4Department of Biostatistics and Medical Informatics. School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706, USA, 5Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53706, USA, 6Department of Stem Cell Biology and Regenerative Medicine, and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA, 7Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA and 8Laboratory of Genetics, University of Wisconsin-Madison, Madison WI, USA
*To whom correspondence should be addressed.
Present address: Shengjie Zhang, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Zhejiang 310022, China.
Abstract
Subunits of the chromatin remodeler SWI/SNF are the most frequently disrupted genes in cancer. However, how post-translational modifications (PTM) of SWI/SNF subunits elicit epigenetic dysfunction remains unknown. Arginine-methylation of BAF155 by coactivator-associated arginine methyltransferase 1 (CARM1) promotes triple-negative breast cancer (TNBC) metastasis. Herein, we discovered the dual roles of methylated-BAF155 (me-BAF155) in promoting tumor metastasis: activation of super-enhancer-addicted oncogenes by recruiting BRD4, and repression of interferon α/γ pathway genes to suppress host immune response. Pharmacological inhibition of CARM1 and BAF155 methylation not only abrogated the expression of an array of oncogenes, but also boosted host immune responses by enhancing the activity and tumor infiltration of cytotoxic T cells. Moreover, strong me-BAF155 staining was detected in circulating tumor cells from metastatic cancer patients. Despite low cytotoxicity, CARM1 inhibitors strongly inhibited TNBC cell migration in vitro, and growth and metastasis in vivo. These findings illustrate a unique mechanism of arginine methylation of a SWI/SNF subunit that drives epigenetic dysregulation, and establishes me-BAF155 as a therapeutic target to enhance immunotherapy efficacy.
논문정보
- Research article
- 2021년 12월 (BRIC 등록일 2021-12-29)
- 국외 연구진
- 의약학 > 종양의학
댓글 작성 로그인
팝업 닫기관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
